Cargando…

The Adenosine A2A Receptor Activation in Nucleus Accumbens Suppress Cue-Induced Reinstatement of Propofol Self-administration in Rats

Propofol has shown strong addictive properties in rats and humans. Adenosine A2A receptors (A2AR) in the nucleus accumbens (NAc) modulate dopamine signal and addictive behaviors such as cocaine- and amphetamine-induced self-administration. However, whether A2AR can modulate propofol addiction remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Zhanglei, Huang, Bingwu, Jiang, Chenchen, Chen, Jiangfan, Lin, Han, Lian, Qingquan, Wu, Binbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053194/
https://www.ncbi.nlm.nih.gov/pubmed/33616808
http://dx.doi.org/10.1007/s11064-021-03238-9
_version_ 1783680073330589696
author Dong, Zhanglei
Huang, Bingwu
Jiang, Chenchen
Chen, Jiangfan
Lin, Han
Lian, Qingquan
Wu, Binbin
author_facet Dong, Zhanglei
Huang, Bingwu
Jiang, Chenchen
Chen, Jiangfan
Lin, Han
Lian, Qingquan
Wu, Binbin
author_sort Dong, Zhanglei
collection PubMed
description Propofol has shown strong addictive properties in rats and humans. Adenosine A2A receptors (A2AR) in the nucleus accumbens (NAc) modulate dopamine signal and addictive behaviors such as cocaine- and amphetamine-induced self-administration. However, whether A2AR can modulate propofol addiction remains unknown. AAV-shA2AR was intra-NAc injected 3 weeks before the propofol self-administration training to test the impacts of NAc A2AR on establishing the self-administration model with fixed ratio 1 (FR1) schedule. Thereafter, the rats were withdrawal from propofol for 14 days and tested cue-induced reinstatement of propofol seeking behavior on day 15. The propofol withdrawal rats received one of the doses of CGS21680 (A2AR agonist, 2.5–10.0 ng/site), MSX-3 (A2AR antagonist, 5.0–20.0 μg/site) or eticlopride (D2 receptor (D2R) antagonist, 0.75–3.0 μg/site) or vehicle via intra-NAc injection before relapse behavior test. The numbers of active and inactive nose-poke response were recorded. Focal knockdown A2AR by shA2AR did not affect the acquisition of propofol self-administration behavior, but enhance cue-induced reinstatement of propofol self-administration compared with the AAV-shCTRLgroup. Pharmacological activation of the A2AR by CGS21680 (≥ 5.0 ng/site) attenuated cue-induced reinstatement of propofol self-administration behavior. Similarly, pharmacological blockade of D2R by eticlopride (0.75–3.0 μg/site) attenuated propofol seeking behavior. These effects were reversed by the administration of MSX-3 (5.0–20.0 μg/site). The A2AR- and D2R-mediated effects on propofol relapse were not confounded by the learning process, and motor activity as the sucrose self-administration and locomotor activity were not affected by all the treatments. This study provides genetic and pharmacological evidence that NAc A2AR activation suppresses cue-induced propofol relapse in rats, possibly by interacting with D2R.
format Online
Article
Text
id pubmed-8053194
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-80531942021-05-05 The Adenosine A2A Receptor Activation in Nucleus Accumbens Suppress Cue-Induced Reinstatement of Propofol Self-administration in Rats Dong, Zhanglei Huang, Bingwu Jiang, Chenchen Chen, Jiangfan Lin, Han Lian, Qingquan Wu, Binbin Neurochem Res Original Paper Propofol has shown strong addictive properties in rats and humans. Adenosine A2A receptors (A2AR) in the nucleus accumbens (NAc) modulate dopamine signal and addictive behaviors such as cocaine- and amphetamine-induced self-administration. However, whether A2AR can modulate propofol addiction remains unknown. AAV-shA2AR was intra-NAc injected 3 weeks before the propofol self-administration training to test the impacts of NAc A2AR on establishing the self-administration model with fixed ratio 1 (FR1) schedule. Thereafter, the rats were withdrawal from propofol for 14 days and tested cue-induced reinstatement of propofol seeking behavior on day 15. The propofol withdrawal rats received one of the doses of CGS21680 (A2AR agonist, 2.5–10.0 ng/site), MSX-3 (A2AR antagonist, 5.0–20.0 μg/site) or eticlopride (D2 receptor (D2R) antagonist, 0.75–3.0 μg/site) or vehicle via intra-NAc injection before relapse behavior test. The numbers of active and inactive nose-poke response were recorded. Focal knockdown A2AR by shA2AR did not affect the acquisition of propofol self-administration behavior, but enhance cue-induced reinstatement of propofol self-administration compared with the AAV-shCTRLgroup. Pharmacological activation of the A2AR by CGS21680 (≥ 5.0 ng/site) attenuated cue-induced reinstatement of propofol self-administration behavior. Similarly, pharmacological blockade of D2R by eticlopride (0.75–3.0 μg/site) attenuated propofol seeking behavior. These effects were reversed by the administration of MSX-3 (5.0–20.0 μg/site). The A2AR- and D2R-mediated effects on propofol relapse were not confounded by the learning process, and motor activity as the sucrose self-administration and locomotor activity were not affected by all the treatments. This study provides genetic and pharmacological evidence that NAc A2AR activation suppresses cue-induced propofol relapse in rats, possibly by interacting with D2R. Springer US 2021-02-22 2021 /pmc/articles/PMC8053194/ /pubmed/33616808 http://dx.doi.org/10.1007/s11064-021-03238-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Paper
Dong, Zhanglei
Huang, Bingwu
Jiang, Chenchen
Chen, Jiangfan
Lin, Han
Lian, Qingquan
Wu, Binbin
The Adenosine A2A Receptor Activation in Nucleus Accumbens Suppress Cue-Induced Reinstatement of Propofol Self-administration in Rats
title The Adenosine A2A Receptor Activation in Nucleus Accumbens Suppress Cue-Induced Reinstatement of Propofol Self-administration in Rats
title_full The Adenosine A2A Receptor Activation in Nucleus Accumbens Suppress Cue-Induced Reinstatement of Propofol Self-administration in Rats
title_fullStr The Adenosine A2A Receptor Activation in Nucleus Accumbens Suppress Cue-Induced Reinstatement of Propofol Self-administration in Rats
title_full_unstemmed The Adenosine A2A Receptor Activation in Nucleus Accumbens Suppress Cue-Induced Reinstatement of Propofol Self-administration in Rats
title_short The Adenosine A2A Receptor Activation in Nucleus Accumbens Suppress Cue-Induced Reinstatement of Propofol Self-administration in Rats
title_sort adenosine a2a receptor activation in nucleus accumbens suppress cue-induced reinstatement of propofol self-administration in rats
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053194/
https://www.ncbi.nlm.nih.gov/pubmed/33616808
http://dx.doi.org/10.1007/s11064-021-03238-9
work_keys_str_mv AT dongzhanglei theadenosinea2areceptoractivationinnucleusaccumbenssuppresscueinducedreinstatementofpropofolselfadministrationinrats
AT huangbingwu theadenosinea2areceptoractivationinnucleusaccumbenssuppresscueinducedreinstatementofpropofolselfadministrationinrats
AT jiangchenchen theadenosinea2areceptoractivationinnucleusaccumbenssuppresscueinducedreinstatementofpropofolselfadministrationinrats
AT chenjiangfan theadenosinea2areceptoractivationinnucleusaccumbenssuppresscueinducedreinstatementofpropofolselfadministrationinrats
AT linhan theadenosinea2areceptoractivationinnucleusaccumbenssuppresscueinducedreinstatementofpropofolselfadministrationinrats
AT lianqingquan theadenosinea2areceptoractivationinnucleusaccumbenssuppresscueinducedreinstatementofpropofolselfadministrationinrats
AT wubinbin theadenosinea2areceptoractivationinnucleusaccumbenssuppresscueinducedreinstatementofpropofolselfadministrationinrats
AT dongzhanglei adenosinea2areceptoractivationinnucleusaccumbenssuppresscueinducedreinstatementofpropofolselfadministrationinrats
AT huangbingwu adenosinea2areceptoractivationinnucleusaccumbenssuppresscueinducedreinstatementofpropofolselfadministrationinrats
AT jiangchenchen adenosinea2areceptoractivationinnucleusaccumbenssuppresscueinducedreinstatementofpropofolselfadministrationinrats
AT chenjiangfan adenosinea2areceptoractivationinnucleusaccumbenssuppresscueinducedreinstatementofpropofolselfadministrationinrats
AT linhan adenosinea2areceptoractivationinnucleusaccumbenssuppresscueinducedreinstatementofpropofolselfadministrationinrats
AT lianqingquan adenosinea2areceptoractivationinnucleusaccumbenssuppresscueinducedreinstatementofpropofolselfadministrationinrats
AT wubinbin adenosinea2areceptoractivationinnucleusaccumbenssuppresscueinducedreinstatementofpropofolselfadministrationinrats